Welcome to your new learning group

To customize this page, click on the wrench at the top left of your screen, then click "dashboard" and "edit."

To add new blocks, click on "choose a category" in the admin menu, then select an option. You will see a list of blocks you can drag and drop to the page.

To delete blocks, hover your cursor over the block and click the gray X.

You can drag and drop blocks from one area of the page to another.

When you are finished, click "done" in the admin menu and then "save changes."

Register Now
Registration is closed.

Whether you are just launching your career in the fields of transplantation or oncology or have been managing transplant or cancer patients for years, this accredited educational activity is designed to deliver the information you need for the care and management of these patient populations.

Faculty consisting of leading medical practitioners from prominent transplant and cancer programs will highlight best practices and strategies to optimize patient/benefit management of individuals undergoing organ or blood/marrow transplant and those with cancer.

During this two-day event you will learn through thought-provoking presentations about advances, trends and updates within these fields including: pre- and posttransplant management, pharmaceuticals, the national policy on organ allocation, and ethical issues. You will also discover the latest guidelines and future applications in transplantation and cancer care, as well as current and emerging strategies to adapt standards and best practices to optimize patient care and outcomes.

Mark your calendar and register today!
Come to learn, earn CME/CE credits, network and have fun!

Registration Fee: $310
Breakfasts, breaks, lunches, reception included! Learn more

Need CME/CE Credits?
Earn up to 12.5 continuing education credits at this conference. Learn more


Designed for the interprofessional health care team

Content has been developed by the health care team to promote collaborative practice in health care delivery by providing a broad range of topics for a variety of learners. The education is intended for health care practitioners that are responsible for the care of transplant and/or oncology patients or management of their benefits, as well as for those who desire to gain or enhance their fundamental knowledge and understanding of transplant medicine and cancer treatments.

** Refer to the Continuing Education page for a listing of certifications that have been applied/approved for this conference.

Who attends?
  • Case Managers
  • Managed Care Nurses
  • Medical Directors
  • Nurses/Oncology Nurses
  • Nurse Practitioners
  • Pharmacists
  • Pharmacy Technicians
  • Physicians/PAs
  • Social Workers
  • Transplant Nurses
  • Transplant/Hematopoietic Transplant Coordinators
  • Medical Management Staff
  • Reinsurance Managers
  • Utilization Review Staff

Conference learning objectives

After completion of this activity, the participant should be able to:

  • Describe changes in the national policy on organ allocation and understand how these changes impact transplant access and organ availability;
  • Recognize the role of immunosuppressive agents in transplantation;
  • Discuss standards of care, the latest guidelines and future applications in lung, heart, and kidney transplantation, as well as in the use of mechanical circulatory assist devices;
  • Explore ethical issues in organ and blood/marrow transplantation;
  • Summarize tolerance induction in kidney transplantation;
  • Identify therapeutic strategies to optimize the management of acute lymphoblastic leukemia (ALL) and in the treatment of Hodgkin lymphoma;
  • State current and emerging strategies to advance the standard of care for patients with graft-versus-host disease;
  • Explore common opportunistic infections and the associated complications among blood/marrow transplant recipients;
  • Determine the impact of a timely referral for blood and marrow transplantation on patient and transplant outcomes; and
  • Explore advances in chimeric antigen receptor (CAR) T-cell immunotherapy for the treatment of malignant disease and the role of precision medicine in cancer care.
Group visibility: 
Public - accessible to all site users
Group description: